Illumina

Our Sandra Agüeros had a breakthrough in cancer treatment thanks to genetic testing. A high-risk mutation fast-tracked her bone marrow transplant—where she uncovered a donor in a sister she never knew she had. This powerful story shows the life-changing potential of genomic insights and their unexpected gifts. 👉 Read about Sandra’s journey of discovery, recovery, and reconnection: https://bit.ly/4oxxRyD

Are you looking for ways to see more from your data? With Illumina 5-base solution, it’s now possible. By connecting genomic variants and methylation in a single run, Illumina 5-base solution brings simplicity, accuracy, and scale together to reveal deeper insights. Hear from the experts and start streamlining your research: https://lnkd.in/dBsKNAmT

At the University of Nebraska Medical Center, comprehensive genomic profiling (CGP) isn’t an add-on — it’s central to how they deliver precision oncology. By bringing testing in-house, Professor Allison M. Cushman-Vokoun and her team are accelerating answers, strengthening collaboration between clinicians, and uncovering biomarkers that directly shape therapy decisions. They’re also using this model to train the next generation of molecular pathologists, ensuring future clinicians gain hands-on experience with modern genomic testing. Their approach reflects the growing impact of bringing advanced sequencing technologies into hospital systems, helping more patients access timely, informed cancer care. Read the full story ➡️ https://lnkd.in/gHaxjiCs

Three days. 120+ global experts. One mission: bring answers to 29 individuals and families living with undiagnosed conditions. The Third Annual Undiagnosed Hackathon took place at the Mayo Clinic in Rochester, Minnesota—its first time in the U.S. Geneticists, bioinformaticians, clinicians, and AI specialists from 28 countries and six continents joined forces with families, sharing stories and searching for answers. Illumina was proud to support this global effort, providing in-kind donations and sending three team members—Aditi Chawla, Richard Wang, PhD, and Shirlene Badger—to collaborate on the tech team. Together, the event delivered six diagnoses and nine significant leads, offering hope and life-changing news to those on the quest for answers. We’re honored to help advance the mission of the Wilhelm Foundation and the Undiagnosed Hackathon, supporting families and experts worldwide. Read the full story: https://bit.ly/43Wca3U

Watch CFO Ankur Dhingra share more about our work in Singapore — a key hub in supporting global innovation in genomics and multiomics. Our longstanding collaboration with the Singapore Economic Development Board (EDB) has been instrumental in cultivating a vibrant biomedical ecosystem in Singapore 👇 

Power your infectious disease surveillance with MiSeq i100. Whether investigating foodborne outbreaks, tracking antimicrobial resistance, or monitoring wastewater, MiSeq i100 delivers same-day viral and bacterial insights, helping labs respond faster and more effectively. Learn how: https://lnkd.in/ghDufHTP

CEO Jacob Thaysen, PhD recently visited China and was interviewed by Caixin Global. He reflected on Illumina’s participation at the 8th China International Import Expo and our continued progress in the China market. Jacob also shared his perspectives on the transformative power of NGS and multiomics, combined with AI to unlock deep biology insights and improve human health. Watch the full video here: https://bit.ly/4is4Umf #CIIE2025

This week is World Antimicrobial Resistance (AMR) Awareness Week, a global campaign to raise awareness of the dangers of AMR—a leading cause of death worldwide. This year’s theme, “Act Now: Protect Our Present, Secure Our Future,” encourages cross-sector systems to take bold, united action in addressing AMR. Illumina is no exception. Around the globe, our WGS and NGS tools are helping scientists improve AMR surveillance, respond to outbreaks, and inform new drug development. Together, we can defeat AMR. https://lnkd.in/gNx4EZ-v #WAAW #AMR #AntimicrobialResistance

For 27 years, Illumina has led the evolution of genomics. Today, through our new BioInsight business, we’re leading its next revolution—genomic AI. Kyle Kai-How Farh MD PhD, Distinguished Scientist and Vice President of AI, shares how BioInsight brings together Illumina’s AI, data, and informatics expertise to make sense of the 40 billion gigabytes of genomic data produced each year. From our flagship algorithms—SpliceAI, PrimateAI-3D, and PromoterAI—to the platforms that scale them, we’re helping researchers and clinicians turn data into discovery faster than ever before. See how we’re taking genomic AI to the next level: https://lnkd.in/gmjz_SVa.

Can we solve a mystery—and find missing heritability insights with whole genome-sequencing? A new study in Nature Portfolio from Illumina and The University of Queensland demonstrates the power of WGS. The findings reveal how both coding and non-coding rare variants contribute to trait heritability—underscoring how WGS offers insights beyond the reach of methods like whole exome sequencing and array-based imputed genotyping. See the figure below for the breakdown and read the full study to explore the traits best explained by WGS: https://lnkd.in/gme_mBwc